Isoniazid, Pyrazinamide, Rifampicin, Ethambutol Hydrochloride — Drug Intelligence | 3 EU Trials

Filter these 3 trials by condition, phase, country and more.

3 Registered trials

2 Recruiting

1 Completed trials

2 Sponsors

2 Countries

Phase II

Phase IV

Phase II: 2 Phase IV: 1

Oversight events:

1 temporary halt across 1 trial

Sponsors using this IMP

3 total

Clinical trial in multiple hospitals to explore new ways to diagnose and monitor tuberculosis treatment Recruiting

2025-522235-34-00 Phase IV 1 country Fundacion Para La Investigacion Biomedica Del Hospital Universitario La Paz
Rifampicin at High Dose for Difficult-to-Treat Tuberculosis (RIAlta) study Recruiting

2024-519983-42-00 Phase II 2 countries Fundacio Hospital Universitari Vall D’Hebron Institut De Recerca
RANDOMIZED, CONTROLLED, OPEN, MULTICENTRIC CLINICAL TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF A COMBINATION OF ANTI-TUBERCULOUS DRUGS BAS… Ended

2023-509075-17-00 Phase II 1 country Fundacio Hospital Universitari Vall D’Hebron Institut De Recerca

Showing 1–3 of 3 trials